This brand name is authorized in Estonia
The drug POLYSPORIN contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Polymyxin B
UNII J2VZ07J96K - POLYMYXIN B
|
|
Polymixin B is bactericidal against a wide range of gram negative bacilli. It exerts a bactericidal effect by binding to acid phospholipids in the cell wall and membranes of the bacterium, thereby rendering ineffective the osmotic barrier normally provided by the cell membrane. |
|
2
Neomycin
UNII I16QD7X297 - NEOMYCIN
|
|
Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code. |
|
3
Gramicidin
UNII 5IE62321P4 - GRAMICIDIN
|
|
Gramicidin is an antimicrobial cyclic polypeptide active in vitro against many gram positive bacteria like Bacillus subtilis and Staphylococcus aureus, but not well against gram-negative ones like E.coli. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| S01AA | Antibiotics | S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1105692, 1268333 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
